| irinotecan / Generic mfg. |
| Unknown status | N/A | 30 | NA | Combined chemotherapy with trabectedin followed by irinotecan | Technische Universität München | Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma, Recurrent Rhabdomyosarcoma | 07/16 | 07/17 | | |
ESTER, NCT03914170: Folfirinox + Cetuximab Chemotherapy, in First Line, With Wild RAS and According to BRAF Status in Metastatic Colorectal Cancer |
|
|
| Completed | N/A | 70 | Europe | Folfirinox + cetuximab | Institut du Cancer de Montpellier - Val d'Aurelle, Merck Serono International SA | Colorectal Cancer | 04/18 | 04/18 | | |
MGMTLiberati, NCT03542097: Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and Irinotecan |
|
|
| Completed | N/A | 82 | Europe | MGMT methylation evaluation | Istituto Ortopedico Rizzoli, Regione Emilia-Romagna | Ewing Sarcoma Family of Tumors | 12/18 | 06/19 | | |
NCT05656222: Irinotecan and Anlotinib for Epithelioid Sarcoma |
|
|
| Withdrawn | N/A | 10 | RoW | VIA combination treatment | Peking University People's Hospital | Objective Response, Overall Survival | 10/24 | 12/24 | | |
